0.5505

3.38% 0.0176

Oragenics Inc (OGEN)

Overview News Price History Discussions Forecast Stock Split

Oragenics Inc stock is traded at $0.5505, with a volume of 183.59K. It is up +3.38% in the last 24 hours and up +0.24% over the past month. Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.

Previous Close:

$0.5329

Open:

$0.54

24h Volume:

183.59K

Relative Volume:

4.67

Market Cap:

$2.47M

Revenue:

$7,500

Net Income/Loss:

$-9.83M

P/E Ratio:

-0.09

EPS:

-6.1164

Net Cash Flow:

$-9.33M

1W Performance:

+0.53%

1M Performance:

+0.24%

6M Performance:

-13.77%

1Y Performance:

-52.10%

1-Day Range:

$0.531

$0.5699

1-Week Range:

$0.5106

$0.5699

52-Week Range:

$0.4801

$1.45

Oragenics Inc Stock (OGEN) Company Profile

Name

Oragenics Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

813-286-7900

Address

4902 Eisenhower Boulevard, Suite 125, Tampa, FL

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

OGEN's Discussions on Twitter

Compare OGEN vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OGEN Oragenics Inc	0.5483	2.40M	7,500	-9.83M	-9.33M	-6.1164
VRTX Vertex Pharmaceuticals Inc	515.52	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.79	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.63	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.26	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.16	39.31B	5.76B	514.49M	1.10B	4.4813

Oragenics Inc Stock (OGEN) Latest News

Aug 13, 2026

Oragenics: Q2 Earnings Snapshot - aol.com

Aug 13, 2026

Oragenics (OGEN) flags going concern risk with $4.7M loss and $3.9M cash - Stock Titan

Aug 13, 2026

Oragenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Jul 31, 2026

OGEN|Oragenics Inc|Price:0.530|Chg%:+0.030 - tradingkey.com

Jul 31, 2026

Jul 27, 2026

Oragenics Inc. Revenue Breakdown – AMEX:OGEN - TradingView

Jul 27, 2026